In conclusion, the field application of the CHF rapid diagnosis kit constructed using the recombinant NT-proBNP antigen developed in this study may reduce costs and replace methods requiring expensive equipment and expertise to diagnose related diseases. Here, NPPB is linked to congestive heart failure.